Literature DB >> 23336347

Impact of Clostridium difficile colitis following closure of a diverting loop ileostomy: results of a matched cohort study.

M Z Wilson1, C S Hollenbeak, D B Stewart.   

Abstract

AIM: Previous reports describing Clostridium difficile colitis (CDC) developing after the closure of a loop ileostomy suggest it is severe. In this study the incidence of CDC following ileostomy closure and its effect on the postoperative outcome have been studied.
METHOD: Patients undergoing closure of loop ileostomy from 2004 to 2008 were analysed using the Nationwide Inpatient Sample. Patients who developed postoperative CDC (n = 217) were matched 10:1 to a propensity-score-matched cohort of patients without CDC (n = 13 245). Linear and logistic regression were used to examine the effect of CDC on hospital cost (US dollars), length of stay and mortality rates. Population resampling was performed using nearest neighbour bootstrapping to confirm the validity of the results.
RESULTS: The incidence of CDC following ileostomy closure was 16 per 1000 patients. The mean length of stay was 11.5 days longer among CDC patients (P < 0.0001), with a greater cost of hospitalization of US$21 240 (P < 0.0001). There was no difference in mortality between the cohorts.
CONCLUSION: CDC following ileostomy closure is an uncommon, costly and morbid complication. Patients undergoing stoma closure are at high risk for an adverse outcome if they have CDC. Should it develop they should be aggressively treated. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  C. difficile; Ileostomy; colitis; post-operative

Mesh:

Year:  2013        PMID: 23336347     DOI: 10.1111/codi.12128

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

1.  Clostridium difficile infection after ileostomy closure mimicking anastomotic leak.

Authors:  Muhammad Qutayba Almerie; Adam Culverwell; Christopher Mahon
Journal:  BMJ Case Rep       Date:  2015-07-06

Review 2.  The economic impact of Clostridium difficile infection: a systematic review.

Authors:  Natasha Nanwa; Tetyana Kendzerska; Murray Krahn; Jeffrey C Kwong; Nick Daneman; William Witteman; Nicole Mittmann; Suzanne M Cadarette; Laura Rosella; Beate Sander
Journal:  Am J Gastroenterol       Date:  2015-04-07       Impact factor: 10.864

3.  Increased postoperative complications after protective ileostomy closure delay: An institutional study.

Authors:  Ines Rubio-Perez; Miguel Leon; Daniel Pastor; Joaquin Diaz Dominguez; Ramon Cantero
Journal:  World J Gastrointest Surg       Date:  2014-09-27

4.  A case report of successful management of fulminant Clostridium difficile colitis post-ileostomy reversal with administration of vancomycin through a transverse colostomy.

Authors:  Keiji Matsuda; Yojiro Hashiguchi; Mitsuo Tsukamoto; Kohei Ohno; Yuka Okada; Takahiro Yagi; Yoshihisa Fukushima; Atsushi Horiuchi; Ryu Shimada; Tsuyoshi Ozawa; Tamuro Hayama; Takeshi Tsuchiya; Junko Tamura; Hisae Iinuma; Keijiro Nozawa; Yuko Sasajima; Fukuo Kondo
Journal:  Surg Case Rep       Date:  2019-11-21

Review 5.  The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review.

Authors:  Annamaria Agnes; Caterina Puccioni; Domenico D'Ugo; Antonio Gasbarrini; Alberto Biondi; Roberto Persiani
Journal:  BMC Surg       Date:  2021-02-12       Impact factor: 2.102

6.  Clostridium difficile infection after ileostomy closure and anastomotic failure in rectal cancer surgery patients.

Authors:  Young Il Kim; Chang Sik Yu; Yang Soo Kim; Chan Wook Kim; Jong Lyul Lee; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Jin Cheon Kim
Journal:  BJS Open       Date:  2022-03-08

Review 7.  Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.

Authors:  Shanshan Zhang; Sarah Palazuelos-Munoz; Evelyn M Balsells; Harish Nair; Ayman Chit; Moe H Kyaw
Journal:  BMC Infect Dis       Date:  2016-08-25       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.